Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca's latest Kondo-izing move: A $250M-plus deal for cancer med Zoladex
AstraZeneca's latest Kondo-izing move: A $250M-plus deal for cancer med Zoladex
AstraZeneca's latest Kondo-izing move: A $250M-plus deal for cancer med Zoladex
Submitted by
admin
on February 21, 2017 - 11:14am
Source:
Fierce Pharma
News Tags:
AstraZeneca
Zoladex
TerSera Therapeutics
Headline:
AstraZeneca's latest Kondo-izing move: A $250M-plus deal for cancer med Zoladex
Do Not Allow Advertisers to Use My Personal information
